1-3 of 3
Bob Shaw
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Acrue: A Phase 2, Open-Label Study of Acalabrutinib in Combination with Rituximab in Elderly and/or Frail Patients with Treatment-Naive Diffuse Large B-Cell Lymphoma

Guilherme F Perini, Tara Graff, Jack Roos, Richard Hermann, Magnus Lovenklev, Bob Shaw, L. Elizabeth Budde
Journal: Blood
Blood (2023) 142 (Supplement 1): 6246.
https://doi.org/10.1182/blood-2023-174769
Published: 2023
Journal Articles

Elevate-TN: Impact of First-Year Dose Modifications in Patients with Treatment-Naive Chronic Lymphocytic Leukemia Treated with Acalabrutinib

George Follows, Alessandra Ferrajoli, John C. Byrd, Bob Shaw, Kenji Nozaki, Katherine Stewart, Paulo Andre P. Palhares De Miranda, Jeff P. Sharman
Journal: Blood
Blood (2023) 142 (Supplement 1): 4645.
https://doi.org/10.1182/blood-2023-174767
Published: 2023
Journal Articles

Analysis of Ventricular Arrhythmias and Sudden Death with Acalabrutinib from 5 Prospective Clinical Trials

Jeff P. Sharman, Paolo Ghia, Paulo Andre P. Palhares De Miranda, Naghmana Bajwa, Simon Rule, Bob Shaw, John F. Seymour
Journal: Blood
Blood (2023) 142 (Supplement 1): 4643.
https://doi.org/10.1182/blood-2023-174913
Published: 2023